Professor Mark Hall addresses U.S. health care reform at a conference in the Netherlands
Research | Comments Off
Office of Communications and Public Relations
December 12, 2011
Professor Mark Hall will speak this week at a conference at Tilburg University in the Netherlands about U.S. health care reform.
The workshop entitled, “Risk adjustment on the market for health care insurance,” will address the fact that in all countries, providing access to health care at affordable prices is a daunting challenge.
Private insurers can play a role in bringing some measure of efficiency but the imperfect functioning of the market can well lead to major shortcomings, as bad risks can end up facing unaffordable health plans or be selected out altogether. Risk adjustment, the practice consisting for health insurance sponsors in compensating insurers for the differences in risks they accept to cover, is typically seen as a useful in addressing those trade-offs.
On Friday, Dec. 16, the Tilburg Law and Economics Center has organized an academic event to take stock of the standard results as well as the recent advances in the field of risk adjustment. This general issue will be discussed in light of a specific experience, namely the reform of the private insurance market in the U.S.
Hall will address “’Reforming private insurance in the US: constitutional and regulatory challenges.”
Among the other presenters are Wynand van de Ven of Erasmus University, who will discuss “Good risk equalization: the only effective stategy to resolve the tradeoff between affordability, efficiency and selection in a competitive market for individual health Insurance,” and Jan Boone of Tilburg University, who will address “Competition leverage: how the demand side affects optimal risk adjustment.” Van de Ven from Erasmus is Europe’s leading expert on risk adjustment, according to Hall.
Hall is one of the nation’s leading scholars in the areas of health care law and policy and medical and bioethics. The author or editor of fifteen books, including Making Medical Spending Decisions (Oxford University Press), and Health Care Law and Ethics (Aspen), he is currently engaged in research in the areas of consumer-driven health care, doctor/patient trust, insurance regulation, and genetics. He has published scholarship in the law reviews at Berkeley, Chicago, Duke, Michigan, Pennsylvania, and Stanford, and his articles have been reprinted in a dozen casebooks and anthologies. Mark also teaches in the MBA program at the Babcock School and is on the research faculty at Wake Forest’s Medical School. He regularly consults with government officials, foundations and think tanks about health care public policy issues.